Enalapril vs Nivolumab

Enalapril vs Nivolumab: Overview

This comparison examines the pharmacological differences between Enalapril and Nivolumab.

Mechanism of Action

Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Enalapril — 11 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Enalapril — C20H28N2O5.

Molecular Weight: Enalapril — 376.4470 g/mol.

Type: Enalapril — Small molecule; Nivolumab — Antibody.